wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38266308-067735DD-8637-4211-AF01-2E4786D99F3A
Q38266308-067735DD-8637-4211-AF01-2E4786D99F3A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38266308-067735DD-8637-4211-AF01-2E4786D99F3A
Personalized treatment of EGFR mutant and ALK-positive patients in NSCLC.
P2860
Q38266308-067735DD-8637-4211-AF01-2E4786D99F3A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38266308-067735DD-8637-4211-AF01-2E4786D99F3A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
03bd24e392e76220be3347aaecddb3d38297b33b
P2860
Prospective assessment of continuation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of pemetrexed.